SCG
BMY icon

Strategic Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Strategic Capital Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$56K Sell
1,163
-440
-27% -$21.7K 0.02% 202
2014
Q1 		$83K Buy
1,603
+926
+137% +$49.3K 0.03% 193
2013
Q4 		$36K Sell
677
-980
-59% -$49.9K 0.03% 192
2013
Q3 		$77K Hold
1,657
– – 0.03% 179
2013
Q2 		$74K Buy
+1,657
New +$71.9K 0.04% 161

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Strategic Capital Group's BMY Position: Q2 2014 in Review

Strategic Capital Group reduced its Bristol-Myers Squibb (BMY) stake by 27% in Q2 2014, selling an estimated $21.7K and leaving 1,163 shares worth $56K. The position accounts for 0.02% of the portfolio, ranked #202.

Strategic Capital Group first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $83K in Q1 2014. 1,301 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

  • Strategic Capital Group held 1,163 shares of Bristol-Myers Squibb worth $56K as of Q2 2014.
  • Strategic Capital Group sold 440 Bristol-Myers Squibb shares in Q2 2014, an estimated $21.7K.
  • Bristol-Myers Squibb made up 0.02% of Strategic Capital Group's portfolio in Q2 2014, its #202 holding.
  • Strategic Capital Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
  • Strategic Capital Group's Bristol-Myers Squibb position peaked at $83K in Q1 2014.
  • 1,301 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Strategic Capital Group's 13F filing for Q2 2014, filed 14 Jul 2014.